COVID-19 Vaccine Report Tops the Most-Shared Studies of August
Post Date: September 3, 2020 | Publish Date:
Cincinnati Children’s is participating in ongoing clinical trials of an mRNA-based vaccine under development by Pfizer and BioNTech.
Robert Frenck, MD, Director, Vaccine Research Center, is leading the local effort and is one of the key co-authors of this study that reports early-stage clinical trial results for the first of two versions of the vaccine, The manufacturer has decided to move forward with the second version.
See below for other widely shared research findings from experts at Cincinnati Children’s.
Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
Article in Nature, August 2020
Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children…
Article in JAMA, August 2020
Association of Nonoperative Management Using Antibiotic Therapy vs Laparoscopic…
Article in JAMA, August 2020
Cincinnati Children’s co-author: Michael Helmrath, MD
Disease-associated KIF3A variants alter gene methylation and expression…
Article in Nature Communications, August 2020
Cincinnati Children’s co-authors: (first author) Mariana Stevens, PhD, Kathryn Wikenheiser-Brokamp, MD, PhD, Matthew Weirauch, PhD, Lisa Martin, PhD, Jocelyn Biagini Myers, PhD, and Gurjit Khurana Hershey, MD, PhD
Effects of Childhood and Adult Persistent Attention-Deficit/Hyperactivity…
Article in Journal of the American Academy of Child & Adolescent Psychiatry, August 2020
Cincinnati Children’s co-author: Jeffery Epstein, PhD
Pathological response in children and adults with large unresected intermediate…
Article in Lancet Oncology, August 2020
Cincinnati Children’s co-author: Joel Sorger, MD
Return to School for Pediatric Solid Organ Transplant Recipients in the United…
Article in Journal of the Pediatric Infectious Diseases Society, August 2020
Cincinnati Children’s co-author: Lara Danziger-Isakov, MD, MPH
